Thomas Steyer Farallon Capital Management
Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$502M |
| 2 |
UnitedHealth
UNH
|
+$254M |
| 3 |
Airbnb
ABNB
|
+$243M |
| 4 |
Aon
AON
|
+$196M |
| 5 |
Sarepta Therapeutics
SRPT
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$311M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$228M |
| 3 |
Blackstone
BX
|
+$222M |
| 4 |
TransUnion
TRU
|
+$203M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$202M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.88% |
| 2 | Technology | 10.2% |
| 3 | Financials | 8.76% |
| 4 | Energy | 8.1% |
| 5 | Industrials | 5.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $6.04B | 25.61% |
11,540,000
-800,000
| -6% | -$398M |
|
|
HES
2
DELISTED
Hess
HES
| $981M | 4.16% |
6,430,000
+3,455,000
| +116% | +$502M |
|
|
PXD
3
DELISTED
Pioneer Natural Resource Co.
PXD
| $924M | 3.92% |
3,520,000
+400,000
| +13% | +$93.8M |
|
|
4
UnitedHealth
UNH
$350B
| $842M | 3.57% |
1,701,410
+498,810
| +41% | +$254M |
|
5
IQVIA
IQV
$42.8B
| $717M | 3.04% |
2,836,162
-124,870
| -4% | -$29.2M |
|
6
Exelixis
EXEL
$13.4B
| $633M | 2.69% |
26,678,500
+44,000
| +0.2% | +$978K |
|
7
Salesforce
CRM
$171B
| $588M | 2.49% |
1,952,168
+26,430
| +1% | +$7.63M |
|
8
Aramark
ARMK
$15.8B
| $580M | 2.46% |
17,822,937
+923,683
| +5% | +$27.8M |
|
9
Nasdaq
NDAQ
$54.9B
| $532M | 2.26% |
8,436,719
+1,866,219
| +28% | +$108M |
|
10
Microsoft
MSFT
$3.59T
| $510M | 2.16% |
1,211,458
-127,120
| -9% | -$51.5M |
|
11
Alphabet (Google) Class C
GOOG
$4.18T
| $508M | 2.16% |
3,337,950
+199,410
| +6% | +$28.8M |
|
|
12
TransUnion
TRU
$16.2B
| $507M | 2.15% |
6,351,256
-2,771,700
| -30% | -$203M |
|
13
New York Times
NYT
$10.6B
| $484M | 2.05% |
11,188,059
+1,711,268
| +18% | +$77.9M |
|
14
PUT
iShares Biotechnology ETF
IBB
$10.7B
| $480M | 2.04% |
+3,500,000
| New | +$478M |
|
|
15
Thermo Fisher Scientific
TMO
$233B
| $463M | 1.97% |
797,416
-405,715
| -34% | -$228M |
|
16
Wabtec
WAB
$50.3B
| $431M | 1.83% |
2,956,398
-981,910
| -25% | -$133M |
|
17
CBRE Group
CBRE
$44B
| $407M | 1.73% |
4,184,030
-61,970
| -1% | -$5.56M |
|
18
Natera
NTRA
$47.9B
| $359M | 1.52% |
3,927,683
+452,800
| +13% | +$34.1M |
|
19
Intuit
INTU
$100B
| $349M | 1.48% |
537,078
+4,078
| +0.8% | +$2.6M |
|
20
S&P Global
SPGI
$127B
| $338M | 1.43% |
793,844
-88,751
| -10% | -$38.5M |
|
|
21
Sarepta Therapeutics
SRPT
$1.98B
| $318M | 1.35% |
2,453,500
+1,243,427
| +103% | +$152M |
|
22
Boston Scientific
BSX
$73B
| $315M | 1.34% |
4,596,657
-1,223,600
| -21% | -$78.7M |
|
23
Analog Devices
ADI
$182B
| $304M | 1.29% |
1,537,990
+48,890
| +3% | +$9.4M |
|
24
ServiceNow
NOW
$133B
| $301M | 1.28% |
1,975,440
-130,810
| -6% | -$19.8M |
|
|
25
Airbnb
ABNB
$110B
| $265M | 1.13% |
+1,608,220
| New | +$243M |
|
Similar funds
Thomas Steyer's Q1 2024 Portfolio in Review
As of Q1 2024, Thomas Steyer held 196 positions worth $23.6B, up 7.8% from $21.9B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Thomas Steyer's Q1 2024 filing shows 43 new, 37 increased, 38 reduced and 21 closed positions. Its largest new stake was Airbnb: 1,608,220 shares worth $265M. The largest sale was Charter Communications, an estimated $311M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Thomas Steyer's largest Q1 2024 buy was Airbnb: 1,608,220 shares worth $265M.
- Thomas Steyer added most to Hess in Q1 2024, an estimated $502M increase.
- Thomas Steyer's biggest Q1 2024 reduction was Thermo Fisher Scientific, cutting an estimated $228M.
- Thomas Steyer fully exited Charter Communications in Q1 2024, selling an estimated $311M.
- Thomas Steyer's ten largest holdings make up 52% of its $23.6B portfolio in Q1 2024.
- Thomas Steyer opened 43 new positions and closed 21 in Q1 2024.
- Thomas Steyer's portfolio value rose 7.8% quarter-over-quarter to $23.6B.
Based on Farallon Capital Management's 13F filing for Q1 2024, filed 15 May 2024.